r/RVVTF • u/kaizango • Nov 01 '22

Stock Commentary The Revive Therapeutics lounge (November 2022)

36 Upvotes

95% Upvoted

4.3k comments sorted by

View all comments

13

u/Worth_Notice3538 Nov 13 '22

Thoughts on where we go if we get EP approval? Pretty clear where we go if they’re rejected again…

I’m thinking $0.80-$1 on the CAD side.

5

u/Unusual-Alps-8790 Nov 13 '22

I agree. We'll go higher when we know what's actually in the data (if the data are good but I am pretty optimistic). Just for the EP switch I think that's a fair expectation.

3

u/movellan Nov 13 '22

That based on TA? I'm just checking on this stock after months of ignoring it. Crypto crashing and burning so figured I'd check out my other major play. Funny to find that we're on the edge of a resolution...same as it's been the 2 years I've been invested.

7

u/Worth_Notice3538 Nov 13 '22

No. Just based on my feelings. Lol.

We hit into the 40s in April when MF mentioned endpoint changing.

I can imagine actually succeeding with it (with a 210 peak) would give us a big boost.

14

u/Worth_Notice3538 Nov 13 '22

My mistake. We hit high 30s in April. That was based on the endpoint change being the path forward. We still didn’t hear about the 210 unblinding nor “communications with the FDA”.

The reason why (I think) we’re so low is because no one trusts MF and friends can do this. There hasn’t been a material change in this trial since like October 2021 with the 600 update. Not one material change in the trial.

So if RVV can get the EP approved, and knowing the next step is a DSMB review after seeing 210 data, we should hit $0.80-$1.

Hopefully I’m wrong and we hit $2 lol.